29
May

In this week’s EuroBiotech Report, Bayer became the most recent biopharma to tap Dutch biotech arGEN-X for its llama-based antibody discovery platform; Eli Lilly made its first-ever investment in a British venture fund; and British biotech Oxford BioMedica hopes to raise £25.7 million to finance its gene therapy pipeline. And more.

…read more

Source: Bayer strikes deal with arGEN-X, Lilly backs U.K. VC fund, Czech biotech in immunotherapy first

    

0 No comments